Trial Profile
An open label, randomised trial evaluating Relative Bioavailabilities of Lisdexamfetamine Dimesylate and D-Amphetamine in Healthy Adults
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Dec 2017
Price :
$35
*
At a glance
- Drugs Dexamfetamine (Primary) ; Lisdexamfetamine (Primary)
- Indications Attention-deficit hyperactivity disorder; Eating disorders; Mood disorders
- Focus Pharmacokinetics
- 11 Dec 2017 New trial record